Artigo Revisado por pares

A Very Frequent Red Cell Antigen, At a

1967; Wiley; Volume: 13; Issue: 5 Linguagem: Inglês

10.1111/j.1423-0410.1967.tb03789.x

ISSN

1423-0410

Autores

F. Applewhaite, Victor Ginsberg, J. Gerena, Charles Cunningham, June Gavin,

Tópico(s)

Parvovirus B19 Infection Studies

Resumo

Vox SanguinisVolume 13, Issue 5 p. 444-445 A Very Frequent Red Cell Antigen, Ata Dr. F. Applewhaite, Corresponding Author Dr. F. Applewhaite Kings County Medical Center, Brooklyn, N.Y., National Bio Serums, Inc., Brooklyn, N.Y. and M.R.C. Blood Group Research Unit The Lister Institute, London *State University of New York, Kings County Medical Center, Brooklyn, N.Y. 2National Bio Serums, Inc., 511, Flushing Avenue, Brooklyn 5, N.Y. (USA) 3Medical Research Council, Blood Group Research Unit, The Lister Institute, Chelsea Bridge Road, London, S.W. 1 (England).Search for more papers by this authorDr. V. Ginsberg, Corresponding Author Dr. V. Ginsberg Kings County Medical Center, Brooklyn, N.Y., National Bio Serums, Inc., Brooklyn, N.Y. and M.R.C. Blood Group Research Unit The Lister Institute, London *State University of New York, Kings County Medical Center, Brooklyn, N.Y. 2National Bio Serums, Inc., 511, Flushing Avenue, Brooklyn 5, N.Y. (USA) 3Medical Research Council, Blood Group Research Unit, The Lister Institute, Chelsea Bridge Road, London, S.W. 1 (England).Search for more papers by this authorMr. J. Gerena, Corresponding Author Mr. J. Gerena Kings County Medical Center, Brooklyn, N.Y., National Bio Serums, Inc., Brooklyn, N.Y. and M.R.C. Blood Group Research Unit The Lister Institute, London *State University of New York, Kings County Medical Center, Brooklyn, N.Y. 2National Bio Serums, Inc., 511, Flushing Avenue, Brooklyn 5, N.Y. (USA) 3Medical Research Council, Blood Group Research Unit, The Lister Institute, Chelsea Bridge Road, London, S.W. 1 (England).Search for more papers by this authorMr. C. A. Cunningham, Corresponding Author Mr. C. A. Cunningham Kings County Medical Center, Brooklyn, N.Y., National Bio Serums, Inc., Brooklyn, N.Y. and M.R.C. Blood Group Research Unit The Lister Institute, London *State University of New York, Kings County Medical Center, Brooklyn, N.Y. 2National Bio Serums, Inc., 511, Flushing Avenue, Brooklyn 5, N.Y. (USA) 3Medical Research Council, Blood Group Research Unit, The Lister Institute, Chelsea Bridge Road, London, S.W. 1 (England).Search for more papers by this authorMiss. June Gavin, Corresponding Author Miss. June Gavin Kings County Medical Center, Brooklyn, N.Y., National Bio Serums, Inc., Brooklyn, N.Y. and M.R.C. Blood Group Research Unit The Lister Institute, London *State University of New York, Kings County Medical Center, Brooklyn, N.Y. 2National Bio Serums, Inc., 511, Flushing Avenue, Brooklyn 5, N.Y. (USA) 3Medical Research Council, Blood Group Research Unit, The Lister Institute, Chelsea Bridge Road, London, S.W. 1 (England).Search for more papers by this author Dr. F. Applewhaite, Corresponding Author Dr. F. Applewhaite Kings County Medical Center, Brooklyn, N.Y., National Bio Serums, Inc., Brooklyn, N.Y. and M.R.C. Blood Group Research Unit The Lister Institute, London *State University of New York, Kings County Medical Center, Brooklyn, N.Y. 2National Bio Serums, Inc., 511, Flushing Avenue, Brooklyn 5, N.Y. (USA) 3Medical Research Council, Blood Group Research Unit, The Lister Institute, Chelsea Bridge Road, London, S.W. 1 (England).Search for more papers by this authorDr. V. Ginsberg, Corresponding Author Dr. V. Ginsberg Kings County Medical Center, Brooklyn, N.Y., National Bio Serums, Inc., Brooklyn, N.Y. and M.R.C. Blood Group Research Unit The Lister Institute, London *State University of New York, Kings County Medical Center, Brooklyn, N.Y. 2National Bio Serums, Inc., 511, Flushing Avenue, Brooklyn 5, N.Y. (USA) 3Medical Research Council, Blood Group Research Unit, The Lister Institute, Chelsea Bridge Road, London, S.W. 1 (England).Search for more papers by this authorMr. J. Gerena, Corresponding Author Mr. J. Gerena Kings County Medical Center, Brooklyn, N.Y., National Bio Serums, Inc., Brooklyn, N.Y. and M.R.C. Blood Group Research Unit The Lister Institute, London *State University of New York, Kings County Medical Center, Brooklyn, N.Y. 2National Bio Serums, Inc., 511, Flushing Avenue, Brooklyn 5, N.Y. (USA) 3Medical Research Council, Blood Group Research Unit, The Lister Institute, Chelsea Bridge Road, London, S.W. 1 (England).Search for more papers by this authorMr. C. A. Cunningham, Corresponding Author Mr. C. A. Cunningham Kings County Medical Center, Brooklyn, N.Y., National Bio Serums, Inc., Brooklyn, N.Y. and M.R.C. Blood Group Research Unit The Lister Institute, London *State University of New York, Kings County Medical Center, Brooklyn, N.Y. 2National Bio Serums, Inc., 511, Flushing Avenue, Brooklyn 5, N.Y. (USA) 3Medical Research Council, Blood Group Research Unit, The Lister Institute, Chelsea Bridge Road, London, S.W. 1 (England).Search for more papers by this authorMiss. June Gavin, Corresponding Author Miss. June Gavin Kings County Medical Center, Brooklyn, N.Y., National Bio Serums, Inc., Brooklyn, N.Y. and M.R.C. Blood Group Research Unit The Lister Institute, London *State University of New York, Kings County Medical Center, Brooklyn, N.Y. 2National Bio Serums, Inc., 511, Flushing Avenue, Brooklyn 5, N.Y. (USA) 3Medical Research Council, Blood Group Research Unit, The Lister Institute, Chelsea Bridge Road, London, S.W. 1 (England).Search for more papers by this author First published: November 1967 https://doi.org/10.1111/j.1423-0410.1967.tb03789.xCitations: 17AboutRelatedInformationPDFPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessClose modalShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article.Citing Literature Volume13, Issue5November 1967Pages 444-445 RelatedInformation RecommendedEnhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole‐cell inactivated pneumococcal vaccineShannon C David, Zoe Laan, Vikrant Minhas, Austen Y Chen, Justin Davies, Timothy R Hirst, Shaun R McColl, Mohammed Alsharifi, James C Paton, Immunology & Cell BiologyAntigen-Specific T-Cell Response from Dendritic Cell Vaccination Using Cancer Stem-Like Cell-Associated AntigensQijin Xu, Gentao Liu, Xiangpeng Yuan, Minlin Xu, Hongqiang Wang, Jianfei Ji, Bindu Konda, Keith L. Black, John S. Yu, STEM CELLSStem cell originated red blood cell cultures: status quo and outlookC. Mazurier, L. Douay, ISBT Science SeriesMouse embryonic stem (ES) cell lines established from neuronal cell‐derived cloned blastocystsEihachiro Kawase, Yukiko Yamazaki, Takeshi Yagi, Ryuzo Yanagimachi, Roger A. Pedersen, genesisWhole cell inactivated autogenous vaccine effectively protects red Nile tilapia (Oreochromis niloticus) against francisellosis via intraperitoneal injectionJosé Gustavo Ramírez-Paredes, Miguel Angel Mendoza-Roldan, Benjamin Lopez-Jimena, Khalid Shahin, Matthijs Metselaar, Kim D. Thompson, David J. Penman, Randolph H. Richards, Alexandra Adams, Journal of Fish Diseases

Referência(s)
Altmetric
PlumX